Myeloproliferative Neoplasms MPN News

CancerConnect Myeloproliferative Neoplasms (MPNs) news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to Myeloproliferative Neoplasms. The unique daily cancer news service evaluates all aspects of Myeloproliferative Neoplasms research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of Myeloproliferative Neoplasms treatment and survivorship.

Share

Myeloproliferative Neoplasms MPN News


CTI BioPharma Announces Removal Of Full Clinical Hold On Pacritinib (January 6, 2017)

CTI BioPharma Corp. announced that the full clinical hold (February 2016) implemented by the U.S. Food and Drug Administration (FDA) on all clinical trials conducted under the Investigational New Drug... Continue Reading

5-Year Survival Improved with Early Use of Jakafi® in Myelofibrosis (December 20, 2016)

An analysis of 5-year data from two large clinical trials provide conclusive support that treatment with Jakafi® (ruxolitinib) improves long-term survival, compared to other treatment options for patients... Continue Reading

Interferon No Better Than Hydroxyurea and Associated with Worse Side Effects in Polycythemia Vera and Essential Thrombocythemia (December 16, 2016)

The use of interferon as initial therapy in MPN is associated with worsening side effects the longer it is used for treatment. These results were recently presented at the 2016 annual meeting of the American... Continue Reading

Duration of Blood Storage Does Not Affect Outcomes for Patients Requiring Blood Transfusions (December 1, 2016)

The length of time that blood is stored prior to a blood transfusion, within normal ranges, does not appear to affect mortality among patients requiring transfusions. These results were recently published... Continue Reading

Myeloproliferative Neoplasms Greatly Affect Patient Quality of Life (October 10, 2016)

According to results from the myeloproliferative neoplasms (MPN) Landmark survey, MPN’s negatively affect the quality of life and overall health of patients even a year before their diagnosis. Myeloproliferative... Continue Reading

About PCROWD, Dana-Farber’s tissue-banking study for patients with Myeloproliferative Neoplasms, Smoldering Multiple Myeloma, Smoldering Waldenstrom’s Macroglobulemia, and Early Myelodysplastic Syndromes (June 27, 2016)

PCROWD (“Precursor CROWDsourcing”) – a tissue banking and clinical information study and repository – is an indispensable component of the blood cancer research pipeline. The main objective... Continue Reading

Jakafi Superior to Standard Treatment in Polycythemia Vera (June 21, 2016)

Treatment with Jakafi® (ruxolitinib) was superior to best available treatment among patients with inadequately controlled polycythemia vera (PV). These results were recently presented at the 21st Congress... Continue Reading

Jakafi Significantly Improves Long-Term Outcomes in Myelofibrosis (June 7, 2016)

The agent Jakafi® (ruxolitinib) has demonstrated significant improvements in long-term outcomes for patients diagnosed with myelofibrosis. These results were recently presented at the 2016 annual meeting... Continue Reading

Polycythemia Vera Today (May 19, 2016)

Polycythemia vera (PV) is a type of blood cancer known as a myeloproliferative neoplasm. It involves the abnormal development and function of bone marrow cells that produce blood cells, and leads to the... Continue Reading

Pacritinib Development in Myelofibrosis Placed on Clinical Hold by the FDA (April 27, 2016)

The investigative agent, pacritinib, being evaluated for treatment of myelofibrosis has been placed on full clinical hold by the United States Food and Drug Administration (FDA). All trials including treatment... Continue Reading

More Myeloproliferative Neoplasms MPN News

Latest Myeloproliferative Neoplasms MPN News By Stage

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS